These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7196888)

  • 1. Antimycobacterial activity of 2-acetylpyridine thiosemicarbazones in relation to their antileprosy activity.
    Morrison NE; Collins FM
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):180-6. PubMed ID: 7196888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between structure and antimycobacterial activity in a series of 2-acetylpyridine thiosemicarbazones.
    Collins FM; Klayman DL; Morrison NE
    J Gen Microbiol; 1982 Jun; 128(6):1349-56. PubMed ID: 6811692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antileprosy activity of some dialkyldithiocarbamates.
    Makarov V; Riabova OB; Yuschenko A; Urlyapova N; Daudova A; Zipfel PF; Möllmann U
    J Antimicrob Chemother; 2006 Jun; 57(6):1134-8. PubMed ID: 16595643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariate analysis of the activity of rifamycins against rapidly growing Mycobacteria, to define an in vitro screening model for their activity against mycobacterium leprae.
    Pattyn SR; Hébrant F
    Arzneimittelforschung; 1980; 30(12):2099-103. PubMed ID: 7011330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of 2-acetylpyridine and 2-acetylquinoline thiosemicarbazones tested in vitro in combination with other antituberculous drugs.
    Collins FM; Klayman DL; Morrison NE
    Am Rev Respir Dis; 1982 Jan; 125(1):58-60. PubMed ID: 6175259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An experimental study of the antileprosy activity of a series of thioamides in the mouse.
    Shepard CC; Jenner PJ; Ellard GA; Lancaster RD
    Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):587-94. PubMed ID: 3910748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Nitrofuran-2-yl derivatives: synthesis and inhibitory activities against growing and dormant mycobacterium species.
    Sriram D; Yogeeswari P; Dhakla P; Senthilkumar P; Banerjee D; Manjashetty TH
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1152-4. PubMed ID: 19131245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antileprosy activity of the newly synthesized benzoxazinorifamycin, KRM-1648.
    Tomioka H; Saito H
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):255-8. PubMed ID: 8371034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of new antitubercular oxazolyl thiosemicarbazones.
    Sriram D; Yogeeswari P; Thirumurugan R; Pavana RK
    J Med Chem; 2006 Jun; 49(12):3448-50. PubMed ID: 16759086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of some antileprosy compounds against Mycobacterium intracellulare in vitro.
    Gangadharam PR; Candler ER
    Am Rev Respir Dis; 1977 Apr; 115(4):705-8. PubMed ID: 557943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent studies of antileprosy drugs.
    Shepard CC; Van Landingham RM; Walker LL
    Lepr Rev; 1983 Jun; Spec No():23-30. PubMed ID: 6350771
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of the quinolone antibacterials against mycobacteria: effect of structural changes at N-1 and C-7.
    Renau TE; Sanchez JP; Gage JW; Dever JA; Shapiro MA; Gracheck SJ; Domagala JM
    J Med Chem; 1996 Feb; 39(3):729-35. PubMed ID: 8576916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antituberculosis activity of 5-methyl/trifluoromethoxy-1H-indole-2,3-dione 3-thiosemicarbazone derivatives.
    Güzel O; Karali N; Salman A
    Bioorg Med Chem; 2008 Oct; 16(19):8976-87. PubMed ID: 18804379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of extracts and constituents of Pelagonium against rapidly growing mycobacteria.
    Seidel V; Taylor PW
    Int J Antimicrob Agents; 2004 Jun; 23(6):613-9. PubMed ID: 15194133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antimycobacterial activity of nitroxanthones. 2nd communication: antimycobacterial activity.
    Ibrom WG; Schaper KJ; Frahm AW
    Arzneimittelforschung; 1997 Jun; 47(6):767-73. PubMed ID: 9239457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of novel metal complexes of 2-acetylpyridine thiosemicarbazones.
    Offiong OE; Martelli S
    Farmaco; 1995 Sep; 50(9):625-32. PubMed ID: 7495474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, antibacterial and antifungal activity of metal (II) complexes of 2-acetylpyridine thiosemicarbazones.
    Offiong OE; Martelli S
    Farmaco; 1993 Jun; 48(6):777-93. PubMed ID: 8373503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Acetylpyridine thiosemicarbazones and Mycobacterium leprae.
    Shepard CC; Klayman DL; Scovill JP; Morrison NE
    Int J Lepr Other Mycobact Dis; 1984 Mar; 52(1):7-9. PubMed ID: 6368429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.